Recruiting Narcolepsy Type 1 Studies in Cincinnati
About Narcolepsy Type 1 Clinical Trials in Cincinnati
Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.
There are currently 2 narcolepsy type 1 clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 242 participants. Research is being sponsored by Alkermes, Inc., Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Type 1 Clinical Trials in Cincinnati — FAQ
Are there narcolepsy type 1 clinical trials in Cincinnati?
Yes, there are 2 narcolepsy type 1 clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cincinnati?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.
Are clinical trials in Cincinnati free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.
What narcolepsy type 1 treatments are being tested?
The 2 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.
Data updated October 15, 2026 from ClinicalTrials.gov